NCT05818462Completed
Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors
Effect of Pelvic Radiation Therapy on the Urinary and Musculoskeletal Systems of Survivors of Childhood Cancer
Source: ClinicalTrials.gov · Last updated 29 Jan 2026
Brief summary (registry, in English)
The aim of this study is to measure and evaluate the effects of pelvic external beam radiation therapy (EBRT) on lower urinary tract (LUT) function and bone mineralization.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 32 (actual)
- First submitted
- 9 Mar 2023
- Start date
- 11 Jul 2023
- Primary completion date
- 2 May 2025
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Childhood cancers
- NCT number
- NCT05818462
What you commit to
- Study type: Observational
- Participants enrolled: 32
- From 11 Jul 2023 to the primary completion date, 2 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with known dysfunctional voiding prior to cancer treatment.
- Patients with tumor resection of bladder, prostate or gynecologic organs will be excluded.
Who the study is looking for
- Patients of any age who were treated were diagnosed in 2007 or later and received chemotherapy for solid tumor malignancy, with completion of therapy (whether chemotherapy or radiation) at least one year prior to study enrollment.
Age in the registry: 2 years to 40 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Colorado Research Center Coordinator of this site? Confirm its status | Aurora | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.